A unique feature of HR is that it repairs the damage to the DNA in a highly accurate way. In eukaryotic cells (those with a ...

A new study reveals the biological secret to the Zika virus's infectious success: Zika uses host cells' own "self-care" ...

Parasites are known to infect human cells through a variety of ingenious mechanisms. Many of them have even evolved sophisticated strategies to evade a host’s immune system by avoiding it entirely.

Researchers have developed a vascularized organoid model of hormone secreting cells in the pancreas. The advance promises to improve diabetes research and cell-based therapies.

Currently, the researchers are using CRISPR-TO to move endogenous RNAs – RNA molecules that are naturally produced within the ...

Somatic hypermutation (SHM) of immunoglobulin variable (V) regions modulates antibody-antigen affinity is initiated by activation-induced cytidine deaminase (AID) on single-stranded DNA (ssDNA).

Figure 1: Expression of pRb and p16 as a function of cell density. Figure 3: hTERT clones undergo normal growth arrest in response to PALA and γ-irradiation. Figure 4: hTERT clones arrest ...

Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat ...

The somatic cell type also affects the efficiency and kinetics ... range of values in accordance with the published studies that reported reprogramming of human cells with either the traditional ...

Worldwide first artificial Human Platelet Lysate (HPL) solution – a key ingredient for the research & production of cell-based pharmaceuticals – developed based on artificial platelet technology from ...

The human brain contains nearly 86 billion neurons, constantly exchanging messages like an immense social media network, but neurons do not work alone – glial cells, neurotransmitters ...

Dr. Desai is the founder of Eyestem Research, a biotechnology company developing scalable cell replacement therapies, based in Karnataka, India. "We have a first-in-human trial ongoing for [retinal ...